
Venture capital
Adjuvant Capital
Adjuvant Capital is a venture capital firm financing life science technologies that tackle high-burden public health problems, especially in low- and middle-income countries, aiming for both social impact and financial returns.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Adjuvant Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Adjuvant Capital joined, from press and the firm’s own posts.
Every round Adjuvant Capital joined
Round sizes, Adjuvant Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Adjuvant Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Adjuvant Capital
Events where Adjuvant Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Adjuvant Capital is based in New York, United States. It also has offices in New York City and Zurich.
2 fund vehicles are on public registers (SEC adviser filings), including ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. and ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.
Sectors: Life sciences. From the firm’s own website.
Backs clinically validated health innovations for neglected infectious diseases, maternal and child health, reproductive health and nutrition in underserved markets. Mainly makes preferred equity investments in technologies with human efficacy data, pursuing double-bottom-line returns. From the firm’s own website.
Adjuvant Capital lists 19 portfolio companies on its website, including LimmaTech Biologics, Memo Therapeutics, Curevo Vaccine, Antiva Biosciences and Pulmocide.
Firms whose websites list some of the same companies include RA Capital, Anzu Partners and Better Ventures.
Know before Adjuvant Capital’s next round is announced.
PRO tracks Adjuvant Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.